---
title: "Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289235134.md"
description: "Bristol Myers Squibb (BMY) shares rose 1.64% to $56.48 on Tuesday, outperforming the S&P 500 but underperforming key competitors like Johnson & Johnson and Pfizer. Trading volume exceeded its 50-day average. The stock remains 10.19% below its 52-week high of $62.89 reached in March."
datetime: "2026-06-09T20:37:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289235134.md)
  - [en](https://longbridge.com/en/news/289235134.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289235134.md)
---

# Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. (BMY) rose 1.64% to $56.48 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.17% to 50,872.11 and the S&P 500 Index falling 0.26% to 7,386.65.

Bristol Myers Squibb Co. closed 10.19% below its 52-week high of $62.89, which the company reached on March 2nd.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 2.08% to $237.00, Pfizer Inc. (PFE) rose 0.31% to $25.70, and Abbott Laboratories (ABT) rose 0.83% to $91.25.

Trading volume (11.9 M) eclipsed its 50-day average volume of 10.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled June 9, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

06-09-26 1637ET

### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [Billionaire Izzy Englander Just Made a Big Bet on This Beaten-Down High-Yield Dividend Stock](https://longbridge.com/en/news/288895535.md)
- [FACTBOX-Major deals involving US drugmakers and biotechs over the past decade](https://longbridge.com/en/news/289163903.md)
- [LJI Wealth Management LLC Takes $2.11 Million Position in Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/285809366.md)
- [waypoint wealth counsel Buys Shares of 22,134 Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/283847222.md)
- [KG&L Capital Management LLC Has $1.07 Million Stock Holdings in Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/271643261.md)